Stock LLY ELI LILLY AND COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Eli Lilly and Company

Equities

LLY

US5324571083

Market Closed - Nyse
Other stock markets
 21:00:02 03/05/2024 BST 		5-day change 1st Jan Change
735 USD -2.77% Intraday chart for Eli Lilly and Company +1.39% +26.08%
05-03 News Highlights : Top Company News of the Day - Friday at 5 PM ET DJ
05-03 News Highlights : Top Company News of the Day - Friday at 7 PM ET DJ

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Eli Lilly, 3M rise; MicroStrategy, Chegg fall, Tuesday, 4/30/2024
AQ
Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues
AQ
Eli Lilly and : Q1 Earnings 2024 Press Release
PU
Eli Lilly and : Q1 Earnings 2024 Earnings Presentation
PU
Lilly: Q1 Earnings Snapshot
AQ
Lilly Reports First-Quarter 2024 Financial Results and Raises Full-Year Revenue Guidance by $2 Billion, Highlights Pipeline Momentum
PR
Eli Lilly and : Lilly Recommends Shareholders Reject “Mini-Tender” Offer by Tutanota LLC
PU
ProQR Highlights Upcoming Presentations on Axiomer RNA Editing at ASGCT 27th Annual Meeting
AQ
Eli Lilly and : Lilly Acquires New Injectable Medicine Manufacturing Facility from Nexus Pharmaceuticals
PU
6 Stocks Positioned to Soar as Investors Focus on MASH
AQ
United Airlines, Eli Lilly rise; JB Hunt, Travelers fall, Wednesday, 4/17/2024
AQ
Lilly Confirms Date and Conference Call for First-Quarter 2024 Financial Results Announcement
PR
Atossa Therapeutics and Quantum Leap Healthcare Announce I-SPY 2 Clinical Trial to Evaluate (Z)-Endoxifen in Combination with Abemaciclib in Women with ER+/HER2- Breast Cancer
AQ
Bayer - AskBio Names Mansuo Shannon Chief Scientific Officer
AQ
Lilly - Results announced from EMPACT-MI phase III trial investigating the effect of Jardiance on risk of heart failure hospitalization and death in adults following a heart attack
AQ
Eli Lilly and : Results announced from EMPACT-MI phase III trial investigating the effect of Jardiance® (empagliflozin) on risk of heart failure hospitalization and death in adults following a heart attack
PU
Eli Lilly and : Q1 Earnings 2024 Estimated Acquired IPR&D And Development Milestone Charges
PU
FDA will take a deeper look into the safety and effectiveness of Lilly experimental Alzheimer's drug
AQ
Eli Lilly and Company - Lilly's Newest Phase of Get Better Campaign Challenges Misperceptions about Obesity Care
AQ
Eli Lilly and : Open Letter Regarding the Use of Mounjaro® (tirzepatide) and Zepbound® (tirzepatide)
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LLY Stock
  4. News Eli Lilly and Company
  5. Press Releases